Malta - Kiingereza - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - adrenaline - solution for injection - adrenaline 1 mg/ml - cardiac therapy

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 8 mg/ml (equivalent: noradrenaline (norepinephrine), qty 4 mg/ml) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 4 mg/ml (equivalent: noradrenaline (norepinephrine), qty 2 mg/ml) - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions).,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

astrazeneca limited - metoprolol tartrate 1 mg/ml;   - solution for injection - 1 mg/ml - active: metoprolol tartrate 1 mg/ml   excipient: sodium chloride water for injection - betaloc iv is indicated for the following indications: · cardiac arrhythmias, especially supraventricular tachycardia, reduction of ventricular rate in atrial fibrillation and ventricular extrasystoles. · suspected or definite myocardial infarction.

Singapoo - Kiingereza - HSA (Health Sciences Authority)

atlantic pharmaceutical (s) pte ltd - adrenaline acid tartrate eqv adrenaline - injection - 1 mg/ml - adrenaline acid tartrate eqv adrenaline 1 mg/ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 1mg/10ml (1 in 10,000) dilute solution for injection pre-filled syringes (martindale pharmaceuticals ltd - adrenaline - solution for injection - 100microgram/1ml

Uingereza - Kiingereza - MHRA (Medicines & Healthcare Products Regulatory Agency)

base) 1mg/10ml (1 in 10,000) dilute solution for injection pre-filled syringes (aguettant ltd - adrenaline - solution for injection - 100microgram/1ml

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - adrenaline (epinephrine) - solution for injection - 1 milligram(s)/millilitre - adrenergic and dopaminergic agents; epinephrine

Malta - Kiingereza - Medicines Authority

teva pharma b.v. swensweg 5, 2031 ga haarlem, netherlands - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents

Malta - Kiingereza - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents